Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide

Regulatory Peptides

Volumn 179, Issue 1-3, 2012, Pages 23-28

  Li, Meixing ^a   Zhou, Lanxia ^a   Ma, Guoning ^a   Dong, Shouliang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Antinociception; Chimeric opioid peptide; Morphiceptin; Neuropeptide FF

Indexed keywords

CYPRODIME; DELTA OPIATE RECEPTOR; MORPHICEPTIN; MORPHICEPTIN DERIVATIVE; MU OPIATE RECEPTOR; NALOXONE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NALTRINDOLE; NEUROPEPTIDE FF; NORBINALTORPHIMINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG STRUCTURE; GUINEA PIG; IC 50; ILEUM; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SMOOTH MUSCLE CONTRACTION; TAIL FLICK TEST; VAS DEFERENS;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDORPHINS; GUINEA PIGS; MALE; MICE; MORPHINANS; NALOXONE; NALTREXONE; NEUROPEPTIDES; OPIOID PEPTIDES; PROLINE; RECEPTORS, NEUROPEPTIDE; TETRAHYDROISOQUINOLINES; TIME FACTORS;

MUS;

EID: 84866271769     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.08.008     Document Type: Article

References (41)

1. Rothman R.B. A review of the role of anti-opioid peptides in morphine-tolerance and dependence. Synapse 1992, 12(2):129-138.
2. Simonnet G., Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain?. Neuroreport 2003, 14(1):1-7.
3. Ossipov M.H., et al. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003, 73(6):783-800.
4. Roumy M., Zajac J.M. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 1998, 345(1):1-11.
5. Mao J.R., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine-tolerance - a current view of their possible interactions. Pain 1995, 62(3):259-274.
6. McNally G.P. Pain facilitatory circuits in the mammalian central nervous system: their behavioral significance and role in morphine analgesic tolerance. Neurosci Biobehav Rev 1999, 23(8):1059-1078.
7. Panula P., Aarnisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 1996, 48(4-5):461-487.
8. Yang H.Y., Iadarola M.J. Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides 2006, 27(5):943-952.
9. Harrison L.M., Kastin A.J., Zadina J.E. Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 1998, 19(9):1603-1630.
10. Laurent P., Becker J.A.J., Valverde O., Ledent C., d'Exaerde A.D., Schiffmann S.N., Maldonado R., Vassart G., Parmentier M. The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. Nat Neurosci 2005, 8(12):1735-1741.
11. Mollereau C., Roumy M., Zajac J.M. Opioid-modulating peptides: mechanisms of action. Curr Top Med Chem 2005, 5(3):341-355.
12. Yang H.Y.T., Tao T., Iadarola M.J. Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides 2008, 42(1):1-18.
13. Kersanté F., et al. Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area. Neurosci Lett 2011, 488:305-309.
14. Wang Y., Wang S., Ma J., Guo J., Fang Q., Sun T., Zhuang Y., Wang R. Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice. Peptides 2011, 32(4):702-706.
15. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.Y.T., Malin D.H. IgG from neuropeptide FF antiserum reverses morphine-tolerance in the rat. Neurosci Lett 1991, 132(1):29-32.
16. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.M. Analogs of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur J Pharmacol 1992, 222(1):61-67.
17. 2) - a potent and specific agonist for morphine (Mu) receptors. Science 1981, 212(4490):75-77.
18. Zadina J., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997, 386:499-502.
19. Widy-Tyszkiewicz E., Członkowski A. Analgesic activity of morphinceptin, β-casomorphin-4, and delta kephalin in normotensive Wistar-Glaxo and spontaneously hypertensive rats. Peptides 1989, 10(3):539-544.
20. Dziadulewicz E.K., Brown M.C., Dunstan A.R., Lee W., Said N.B., Garratt P.J. The design of non-peptide human bradykinin B-12 receptor antagonists employing the benzodiazepine peptidomimetic scaffold. Bioorg Med Chem Lett 1999, 9(3):463-468.
21. Chen J.C., Li J.Y., Liang K.W., Huang Y.K. Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex. Brain Res 1999, 816(1):220-224.
22. Tan P.P.C., Chen J.C., Li J.Y., Liang K.W., Wong C.H., Huang E.Y.K. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides 1999, 20(10):1211-1217.
23. Engström M., Wurster S., Savola J.M., Panula P. Functional properties of PFR(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors. Peptides 2003, 24(12):1947-1954.
24. Huang E.Y.K., Li J.Y., Tan P.P.C., Wong C.H., Chen J.C. The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF). Peptides 2000, 21(2):205-210.
25. 2 antiserum. Neuropeptides 1987, 10(1):37-42.
26. Chen J.C., Lee W.H., Chen P.C., Tseng C.P., Huang E.Y.K. Rat NPFF1 receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide. Peptides 2006, 27(5):1005-1014.
27. Haley T.M., McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 1957, 12(1):12-15.
28. Yang Y.L., Dong S.L. Effects of endokinin A/B and endokinin C/D on the modulation of pain in mice. Peptides 2010, 31(1):94-100.
29. Wang J., Wang L., Li M., Jin Q., Dong S. Preliminary analgesic properties of deltorphin-5-methoxytryptamine chimeric opioid peptides. Peptides 2011, 32(5):1055-1059.
30. Yang Y.L., Ni Z.Q., Dong S.L. Effects of endokinin A/B and endokinin C/D on the antinociception of endomorphin-1 in mice. Peptides 2010, 31(4):689-695.
31. Goldberg I.E., Rossi G.C., Letchworth S.R., Mathis J.P., Ryan-Moro J., Leventhal L., Su W., Emmel D., Bolan E.A., Pasternak G.W. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 1998, 286(2):1007-1013.
32. Fichna J., Gach K., Piestrzeniewicz M., Burgeon E., Poels J., Vanden Broeck J., Janecka A. Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay. J Pharmacol Exp Ther 2006, 317(3):1150-1154.
33. Ward S.J., Lopresti D., James D.W. Activity of mu-selective and delta-selective opioid agonists in the guinea-pig ileum preparation - differentiation into peptide and nonpeptide classes with beta-funaltrexamine. J Pharmacol Exp Ther 1986, 238(2):625-631.
34. Mollereau C., Gouarderes C., Dumont Y., Kotani M., Detheux M., Doods H., Parmentier M, Quirion R., Zajac JM.. Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226. Br J Pharmacol 2009, 133(1):1-4.
35. Fichna J., do-Rego J.C., Costentin J., Chung N.N., Schiller P.W., Kosson P., Janecka A. Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs. Biochem Biophys Res Commun 2004, 320(2):531-536.
36. Jordan B.A., Cvejic Svetlana, Devi Lakshmi A. Opioids and their complicated receptor complexes. Neuropsychopharmacology 2000, 23(4, Supplement 1):S5-S18.
37. Rapaka R.S., Porreca F. Development of delta opioid peptides as nonaddicting analgesics. Pharm Res 1991, 8(1):1-8.
38. Ananthan S. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS J 2006, 8(1):E118-E125.
39. Takemori A.E., Vaught J.L. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J Pharmacol Exp Ther 1979, 208(1):86-90.
40. Oberling P., Stinus L., Lemoal M., Simonnet G. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides 1993, 14(5):919-924.
41. Gouardères C., Sutak M., Zajac J.M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 1993, 237(1):73-81.